Panchsheel Organics Ltd

Panchsheel Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Panchsheel Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Panchsheel Organics Ltd., the Indore-based pharmaceutical manufacturer specialising in Active Pharma Ingredients and finished formulations, reported a net profit of ₹3.68 crores for Q3 FY26 (Oct-Dec'25), marking a sequential improvement of 41.00% from Q2 FY26's ₹2.61 crores. Despite this quarterly recovery, the ₹158.06 crore market capitalisation company continues to grapple with structural margin pressures that have persisted across recent quarters, raising questions about the sustainability of profitability amidst tepid revenue growth.

Panchsheel Organics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended December 2025, signalling a stabilisation after a period of decline. Despite posting its highest quarterly profit after tax (PAT) and earnings per share (EPS) in recent history, the company continues to face challenges with its return on capital employed (ROCE), which remains at a multi-quarter low. This mixed financial trend has prompted a downgrade in the company’s Mojo Grade from Hold to Sell as of 6 January 2025.

Panchsheel Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 January 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Panchsheel Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 January 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trend, and technical outlook.

Panchsheel Organics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.103 today, marking a significant decline amid a broader market downturn and persistent underperformance against benchmarks.

Panchsheel Organics Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.105.65 today, marking a significant decline amid ongoing underperformance relative to its sector and benchmark indices.

Panchsheel Organics Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.123.05 today, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance metrics.

Panchsheel Organics Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.123.35 today, marking a significant decline in its share price amid broader market fluctuations and company-specific performance factors.

Panchsheel Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Panchsheel Organics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.123.6 today, marking a significant decline amid a broader market environment that remains relatively stable. The stock’s recent performance reflects ongoing pressures that have weighed on its valuation and market sentiment.

Panchsheel Organics Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.125.2 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and benchmark indices, reflecting ongoing pressures on its financial performance and market valuation.

Panchsheel Organics Ltd, a player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.125.2 today, marking a significant decline amid ongoing underperformance relative to its sector and benchmark indices.

Panchsheel Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date view of the company's performance and outlook.

Panch.Organics, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting shifts in its financial and technical outlook. This adjustment follows a period marked by subdued profitability and bearish technical indicators, prompting a reassessment of the company’s standing among investors.